Epithalon (Epitalon) – 100mg | Research Compound

Epithalon – 100mg | Research Compound

Epithalon is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). Developed within the Khavinson peptide research program, it is studied in laboratory settings for its molecular characteristics, gene-expression interactions, and related cellular pathways.

Key Research Areas:

• Telomerase Research — Laboratory investigation of Epithalon in relation to telomerase-associated molecular activity and telomere-related cellular processes.
• Gene-Expression Research — Investigation of gene-expression patterns and molecular regulatory mechanisms associated with the AEDG peptide sequence.
• Peptide-DNA Interaction Research — Research examining proposed interactions between short-chain peptides and DNA-associated regulatory mechanisms.
• Cellular Signaling Research — Laboratory characterization of Epithalon-associated cellular and molecular signaling pathways.
• Comparative Peptide Research — Comparative investigation of Epithalon and structurally related short-chain peptide bioregulators.

Product Specifications:

• Sequence: Ala-Glu-Asp-Gly (AEDG)
• Molecular Formula: C₁₄H₂₂N₄O₉
• Molecular Weight: ~390.3 g/mol
• 100mg lyophilized research compound per vial
• ≥99% purity via HPLC
• Third-party COA available
• Store under appropriate controlled laboratory conditions and protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic. Not FDA-approved.